147 related articles for article (PubMed ID: 1906368)
21. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK
J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209
[TBL] [Abstract][Full Text] [Related]
22. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
[TBL] [Abstract][Full Text] [Related]
23. [Autologous bone marrow transplantation in pediatric cancer].
Ohira M
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
[TBL] [Abstract][Full Text] [Related]
24. Improved prognosis for children with stage IV neuroblastoma: high-dose melphalan and autologous unpurged marrow transplantation after aggressive surgery and short chemotherapy with cisplatinum and etoposide.
Rajantie J; Wikström S; Perkkiö M; Hovi L; Mäkipernaa A; Maunuksela EL; Siimes MA
Pediatr Hematol Oncol; 1988; 5(2):125-35. PubMed ID: 3152958
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. The Northern Regional Bone Marrow Transplant Group.
Carey PJ; Proctor SJ; Taylor P; Hamilton PJ
Blood; 1991 Apr; 77(7):1593-8. PubMed ID: 2009375
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
27. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
Corbett R; Pinkerton R; Pritchard J; Meller S; Lewis I; Kingston J; McElwain T
Eur J Cancer; 1992; 28A(8-9):1324-8. PubMed ID: 1515243
[TBL] [Abstract][Full Text] [Related]
28. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children].
Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J
Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274
[TBL] [Abstract][Full Text] [Related]
29. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
[TBL] [Abstract][Full Text] [Related]
30. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia.
Simonsson B; Burnett AK; Prentice HG; Hann IH; Brenner MK; Gibson B; Grob JP; Lönnerholm G; Morrison A; Smedmyr B
Leukemia; 1989 Sep; 3(9):631-6. PubMed ID: 2668654
[TBL] [Abstract][Full Text] [Related]
31. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.
Gaspard MH; Maraninchi D; Stoppa AM; Gastaut JA; Michel G; Tubiana N; Blaise D; Novakovitch G; Rossi JF; Weiller PJ
Cancer Chemother Pharmacol; 1988; 22(3):256-62. PubMed ID: 3044633
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors.
Jagannath S; Barlogie B; Dicke K; Alexanian R; Zagars G; Cheson B; Lemaistre FC; Smallwood L; Pruitt K; Dixon DO
Blood; 1990 Nov; 76(9):1860-6. PubMed ID: 2224133
[TBL] [Abstract][Full Text] [Related]
33. Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro.
Kushner BH; Gulati SC; O'Reilly RJ; Heller G; Cheung NK
Med Pediatr Oncol; 1990; 18(6):454-8. PubMed ID: 2135871
[TBL] [Abstract][Full Text] [Related]
34. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.
Gonzales-Chambers R; Przepiorka D; Shadduck RK; Borochovitz D; Bloom EJ; Colvin OM; Mangan KF; Rosenfeld CS
Med Pediatr Oncol; 1991; 19(3):160-4. PubMed ID: 2023563
[TBL] [Abstract][Full Text] [Related]
35. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Saarinen UM; Sariola H; Hovi L
Am J Pediatr Hematol Oncol; 1991; 13(3):315-9. PubMed ID: 1793158
[TBL] [Abstract][Full Text] [Related]
36. Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma.
Kletzel M; Becton DL; Berry DH
Med Pediatr Oncol; 1992; 20(1):64-7. PubMed ID: 1530757
[TBL] [Abstract][Full Text] [Related]
37. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation.
Seeger RC; Reynolds CP
Pediatr Clin North Am; 1991 Apr; 38(2):393-424. PubMed ID: 2006084
[TBL] [Abstract][Full Text] [Related]
38. Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer.
Souhami RL; Hajichristou HT; Miles DW; Earl HM; Harper PG; Ash CM; Goldstone AH; Spiro SG; Geddes DM; Tobias JS
Cancer Chemother Pharmacol; 1989; 24(5):321-5. PubMed ID: 2547528
[TBL] [Abstract][Full Text] [Related]
39. Intensive combined therapy for previously untreated aggressive myeloma.
Attal M; Huguet F; Schlaifer D; Payen C; Laroche M; Fournie B; Mazieres B; Pris J; Laurent G
Blood; 1992 Mar; 79(5):1130-6. PubMed ID: 1536941
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma.
Anderson KC; Barut BA; Ritz J; Freedman AS; Takvorian T; Rabinowe SN; Soiffer R; Heflin L; Coral F; Dear K
Blood; 1991 Feb; 77(4):712-20. PubMed ID: 1993214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
